AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma

Summary

The goal of treatment with AICS is weaning from oral corticosteroids, i.e. a reduction of the oral corticosteroid dose. An anticipated treatment benefit of AICS is a reduction of oral corticosteroid dose and stability/improvement of clinical parameters related to asthma in the targeted subject population. Ultimately, the goal is to free subjects with severe asthma from the burden of chronic oral steroid therapy.

Timeline

Start

2010-03

Primary completion

2011-10

Completion

2011-11

Drugs

Indications